← Leaderboards
Ryan W Barrs
Clemson University
$105,553
Attributed
$105,553
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $40K · FY2021–23$50K$37.5K$25K$12.5K$0
'21
'22
'23
Funding mix
By agency
NIH$105,553 · 1
By mechanism
F31$105,553 · 1
Top collaborators
No co-investigators on record.
Most similar at Clemson University
Same institution · by research overlap
- Ying Mei$5,777,839
- Hai Yao$18,362,489
- Agneta Simionescu$2,540,423
- Naren R. Vyavahare$20,824,854
- Ravikiran Singapogu$1,980,502
Others in their field
Other Emerging Leaders on “Echocardiography”
- Federico Cividini · Cardiac Rsk3 Inhibitors, Llc$10,485,488
- Ionut Bebu · George Washington University$10,066,665
- Barbara Halina Braffett · George Washington University$10,066,665
- Bruce Psaty · University Of Washington$7,081,269
- Christoph Hornik · Duke University$5,628,142
- Wendy White · Tougaloo College$5,121,211
Research focus
EchocardiographyEndothelial CellsAffect3-DimensionalElectrocardiogramAnimal ModelAnimalsBiological ProcessBlood VesselsAnastomosis - ActionAdvanced DevelopmentAngiogenesisCardiac RepairCardiac Tissue EngineeringCardiovascular DiseasesCause Of DeathCellsCell SurvivalCell TherapyCessation Of LifeClinical ApplicationClinical TranslationCardiacEndothelium
Grant awards (3)
Leveraging the HIF-alpha pathway to improve the engraftment and therapeutic efficacy of human nanowired cardiac organoids$26,259
F31 · FY2023 · HL · contact PI
Leveraging the HIF-alpha pathway to improve the engraftment and therapeutic efficacy of human nanowired cardiac organoids$40,005
F31 · FY2022 · HL · contact PI
Leveraging the HIF-alpha pathway to improve the engraftment and therapeutic efficacy of human nanowired cardiac organoids$39,289
F31 · FY2021 · HL · contact PI